Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 344

1.

Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score.

Smith JG, Wieloch M, Koul S, Braun OÖ, Lumsden J, Rydell E, Ohman J, Scherstén F, Svensson PJ, van der Pals J.

EuroIntervention. 2012 Oct;8(6):672-8. doi: 10.4244/EIJV8I6A105.

2.

Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.

Braun OÖ, Bico B, Chaudhry U, Wagner H, Koul S, Tydén P, Scherstén F, Jovinge S, Svensson PJ, Gustav Smith J, van der Pals J.

Thromb Res. 2015 Jan;135(1):26-30. doi: 10.1016/j.thromres.2014.10.016. Epub 2014 Oct 24.

PMID:
25467434
3.

Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study.

Lamberts M, Olesen JB, Ruwald MH, Hansen CM, Karasoy D, Kristensen SL, Køber L, Torp-Pedersen C, Gislason GH, Hansen ML.

Circulation. 2012 Sep 4;126(10):1185-93. doi: 10.1161/CIRCULATIONAHA.112.114967. Epub 2012 Aug 6.

4.

Safety of the cardiac triple therapy: the experience of the Quebec Heart Institute.

Brulotte S, Sénéchal M, Poirier P, Nguyen CM, Lemieux A, Magne J, Bergeron S.

Can J Cardiol. 2007 Oct;23 Suppl B:80B-83B. Erratum in: Can J Cardiol. 2009 Mar;25(3):140.

7.

Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding.

Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, Wong SC, Hong MK.

J Invasive Cardiol. 2006 Apr;18(4):162-4.

PMID:
16729401
8.

Triple antithrombotic therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.

Kang DO, Yu CW, Kim HD, Cho JY, Joo HJ, Choi RK, Park JS, Lee HJ, Kim JS, Park JH, Hong SJ, Lim DS.

Coron Artery Dis. 2015 Aug;26(5):372-80. doi: 10.1097/MCA.0000000000000242.

PMID:
25768244
9.

Prognostic implications of early and long-term bleeding events in patients on one-year dual antiplatelet therapy following drug-eluting stent implantation.

Musumeci G, Rossini R, Lettieri C, Capodanno D, Romano M, Rosiello R, Guagliumi G, Valsecchi O, Gavazzi A, Angiolillo DJ.

Catheter Cardiovasc Interv. 2012 Sep 1;80(3):395-405. doi: 10.1002/ccd.23337. Epub 2012 Jan 10.

PMID:
22109961
10.

Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation.

Suh SY, Kang WC, Oh PC, Choi H, Moon CI, Lee K, Han SH, Ahn T, Choi IS, Shin EK.

Heart Vessels. 2014 Sep;29(5):578-83. doi: 10.1007/s00380-013-0399-x. Epub 2013 Aug 24.

PMID:
23974943
11.

Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.

Manzano-Fernández S, Pastor FJ, Marín F, Cambronero F, Caro C, Pascual-Figal DA, Garrido IP, Pinar E, Valdés M, Lip GY.

Chest. 2008 Sep;134(3):559-67. doi: 10.1378/chest.08-0350. Epub 2008 Jul 18.

PMID:
18641090
12.

Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.

DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, Lam L, McGowan C, Lee G, DeCaro M, Ruggiero N, Singhal S, Greenspon A.

Pharmacotherapy. 2007 May;27(5):691-6.

PMID:
17461704
13.

Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes.

Lopes RD, Li L, Granger CB, Wang TY, Foody JM, Funk M, Peterson ED, Alexander KP.

Am J Med. 2012 Sep;125(9):897-905. doi: 10.1016/j.amjmed.2012.04.006. Epub 2012 Jul 13.

PMID:
22795814
14.

Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.

Wang TY, Robinson LA, Ou FS, Roe MT, Ohman EM, Gibler WB, Smith SC Jr, Peterson ED, Becker RC.

Am Heart J. 2008 Feb;155(2):361-8. doi: 10.1016/j.ahj.2007.09.003. Epub 2007 Oct 25.

PMID:
18215609
15.

Aspirin, clopidogrel, and warfarin: is the combination appropriate and effective or inappropriate and too dangerous?

Hermosillo AJ, Spinler SA.

Ann Pharmacother. 2008 Jun;42(6):790-805. doi: 10.1345/aph.1K591. Epub 2008 May 13. Review. Erratum in: Ann Pharmacother. 2008 Oct;42(10):1521.

PMID:
18477734
17.

Efficacy and safety of optimized antithrombotic therapy with aspirin, clopidogrel and enoxaparin in patients with non-ST segment elevation acute coronary syndromes in clinical practice.

Heer T, Juenger C, Gitt AK, Bauer T, Towae F, Zahn R, Senges J, Zeymer U; Acute Coronary Syndromes (ACOS) Registry Investigators.

J Thromb Thrombolysis. 2009 Oct;28(3):325-32. doi: 10.1007/s11239-008-0294-y. Epub 2008 Dec 20.

PMID:
19101783
18.

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.

Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB.

Am Heart J. 2004 Mar;147(3):463-7.

PMID:
14999195
19.

Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy.

Fosbol EL, Wang TY, Li S, Piccini J, Lopes RD, Mills RM, Klaskala W, Thomas L, Roe MT, Peterson ED.

Am Heart J. 2013 Nov;166(5):864-70. doi: 10.1016/j.ahj.2013.08.005. Epub 2013 Sep 17.

PMID:
24176442
20.

Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?

Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, Budaj A, Gulba DC, Allegrone J, Brieger D; GRACE Investigators.

Eur Heart J. 2007 Jul;28(14):1717-22. Epub 2007 Jun 11.

Items per page

Supplemental Content

Write to the Help Desk